Elamipretide: a mitochondria-targeting drug for Barth syndrome

Journal article published in Trends in pharmacological sciences (2026) covering SS-31.

Journal article.

The record

Peptide profiles: SS-31.

All indexed evidence: SS-31 trials & papers.

Related studies: Pre-qualifications, learning strategies, and study satisfaction among medical students:…, Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence, Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets…, Elamipretide in pediatric Barth syndrome: from heart failure to school return.